Education
About Us
Working with TipRanks
Follow Us
DLH Holdings (DLHC)
NASDAQ:DLHC
DLHC Stock Chart & Stats
$5.56
$0.05(0.65%)
At close: 4:00 PM EST
$5.56
$0.05(0.65%)
Day’s Range― - ―
52-Week Range$2.72 - $8.10
Previous CloseN/A
Volume6.05K
Average Volume (3M)27.65K
Market Cap
$80.58M
Enterprise Value$230.13M
Total Cash (Recent Filing)$257.00K
Total Debt (Recent Filing)$149.80M
Price to Earnings (P/E)―
Beta1.25
Next Earnings
May 06, 2026EPS Estimate
-0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding14,493,035
10 Day Avg. Volume37,306
30 Day Avg. Volume27,646
Financial Highlights & Ratios
PEG Ratio-0.73
Price to Book (P/B)0.72
Price to Sales (P/S)0.24
P/FCF Ratio3.54
Enterprise Value/Market Cap2.86
Enterprise Value/Revenue0.71
Enterprise Value/Gross Profit7.78
Enterprise Value/Ebitda7.83
Forecast
1Y Price Target
$10.00Price Target Upside79.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationDLH's trailing twelve-month operating cash flow (~$30M) and free cash flow (~$31.1M) with strong FCF growth (+30.8%) demonstrate durable cash conversion. Reliable cash generation supports working capital, funds capex and debt reduction, and provides flexibility during revenue volatility, underpinning execution of strategic initiatives.
Defensive Federal Contracting FootprintDLH's core business serving federal health and defense agencies via long-term contracts creates recurring revenue and high switching costs. Exposure to modernization and healthcare mandates gives structural demand, making its business model resilient to cyclical commercial downturns and attractive to agencies requiring continuity and compliance.
Clear Deleveraging And Cost ActionsManagement's explicit plan to allocate roughly half of FY2026 EBITDA to debt reduction, together with phased indirect cost reductions and AI efficiency initiatives, is a durable governance signal. If executed, it should lower leverage, improve interest coverage and sustain margin recovery over the medium term while preserving covenant compliance.
Bears Say
Revenue Decline And Margin CompressionSustained revenue declines and significantly compressed gross margins materially weaken DLH's earnings power. Lower top-line volumes and margin erosion reduce free earnings available for deleveraging or reinvestment, increasing sensitivity to contract timing and making margin recovery necessary to restore durable profitability.
Elevated LeverageDespite improvement, debt-to-equity near 1.28 is elevated relative to current profitability. High leverage constrains strategic flexibility, raises interest and covenant risk if earnings falter, and makes the company reliant on successful cash conversion and asset performance to avoid refinancing stress during prolonged revenue weakness.
Program Transitions And Weak PipelineStructural shifts of programs to small-business set-asides and muted bid activity reduce DLH's addressable pipeline and prime contracting opportunities. Losing scope or prime positions on vehicles and delayed awards can permanently lower revenue run-rate and hinder scale benefits, making growth recovery more uncertain over the medium term.
DLH Holdings News
DLHC FAQ
What was DLH Holdings’s price range in the past 12 months?
DLH Holdings lowest stock price was $2.72 and its highest was $8.10 in the past 12 months.
What is DLH Holdings’s market cap?
DLH Holdings’s market cap is $80.58M.
When is DLH Holdings’s upcoming earnings report date?
DLH Holdings’s upcoming earnings report date is May 06, 2026 which is in 79 days.
How were DLH Holdings’s earnings last quarter?
DLH Holdings released its earnings results on Feb 09, 2026. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.02.
Is DLH Holdings overvalued?
According to Wall Street analysts DLH Holdings’s price is currently Undervalued.
Does DLH Holdings pay dividends?
DLH Holdings does not currently pay dividends.
What is DLH Holdings’s EPS estimate?
DLH Holdings’s EPS estimate is -0.16.
How many shares outstanding does DLH Holdings have?
DLH Holdings has 14,493,035 shares outstanding.
What happened to DLH Holdings’s price movement after its last earnings report?
DLH Holdings reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went down -4.795%.
Which hedge fund is a major shareholder of DLH Holdings?
Currently, no hedge funds are holding shares in DLHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DLH Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (79.86% Upside)
$10.00 (79.86% Upside)
Insider Transactions
Bought Shares
Worth $352.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-26.72%
12-Months-Change
Fundamentals
Return on Equity
1.22%
Trailing 12-Months
Asset Growth
-7.54%
Trailing 12-Months
Company Description
DLH Holdings
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. The company offers defense and veterans' health solutions, including healthcare, technology, and logistics solutions to the VA, Defense Health Agency, Tele-medicine and Advanced Technology Research Center, Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. It also provides a range of human services and solutions, which consists of monitoring and evaluation, electronic medical records migration, data collection and management, and nutritional and social health assessments; and IT system architecture design, migration plan, and ongoing maintenance services. In addition, the company offers public health and life sciences services, such as clinical trials, epidemiology studies, and disease prevention; and health promotion to underserved and at-risk communities through development of strategic communication campaigns, research on emerging trends, health informatics analyses, and application of best practices. It primarily serves the federal health services market. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.
DLHC Company Deck
DLHC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a mixed but constructive outlook. Short-term financial results show meaningful year-over-year revenue and EBITDA declines (revenue down ~24.1%, adjusted EBITDA down ~34.3%) driven primarily by program transitions to small-business set-asides and limited bid activity. Offsetting factors include improved budget clarity for fiscal 2026, sequential margin improvement to 9.5%, significant year-over-year free cash flow improvement (reduction in cash usage of ~$7.3M), active indirect cost reductions, and a clear deleveraging plan (targeting conversion of ~50%–55% of FY2026 EBITDA to debt reduction). Management emphasized market positioning in modernization, cybersecurity and AI, and expects more stable procurement activity going forward. On balance, positives (improved visibility, cost actions, cash improvement and debt-reduction plan) temper but do not fully offset the sizable near-term revenue and profitability headwinds.View all DLHC earnings summariesDLHC Stock 12 Month Forecast
Average Price Target
$10.00
▲(79.86% Upside)